Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T70532 | Target Info | |||
Target Name | NCK adaptor protein 1 (NCK1) | ||||
Synonyms | SH2/SH3 adaptor protein NCKalpha; SH2/SH3 adaptor protein NCK-alpha; Nck1; Nck-1; NCK; Cytoplasmic protein NCK1 | ||||
Target Type | Clinical trial Target | ||||
Gene Name | NCK1 | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Acyltransferases | [+] 1 Acyltransferases | + | |||
Interacting Target Name | Signal transduction protein CBL (CBL) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RNF55; RING-type E3 ubiquitin transferase CBL; RING finger protein 55; Proto-oncogene c-CBL; E3 ubiquitin-protein ligase CBL; C-Cbl; CBL2; Casitas B-lineage lymphoma proto-oncogene | ||||
Evidence Score (E-score) | 7 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Affinity Capture-Western | [3] | |||
4 | Affinity Capture-Western | [4] | |||
5 | Reconstituted Complex | [4] | |||
6 | Reconstituted Complex | [5] | |||
7 | Reconstituted Complex | [3] | |||
Kinases | [+] 6 Kinases | + | |||
Interacting Target Name | Epidermal growth factor receptor (EGFR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Epidermal growth factor receptor variant III; Proto-oncogene c-ErbB-1 variant III; Receptor tyrosine-protein kinase erbB-1 variant III; EGFR variant III; ERBB variant III; ERBB1 variant III; HER1 variant III | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [6] | |||
2 | Affinity Capture-Western | [7] | |||
3 | Protein-Fragment Complementation Assay | [8] | |||
4 | Protein-peptide | [9] | |||
5 | Reconstituted Complex | [10] | |||
6 | Yeast two hybrid | [11] | |||
Interacting Target Name | MEK kinase kinase 1 (MAP4K1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Mitogen-activated protein kinase kinase kinase kinase 1; MEKKK 1; MAPK/ERK kinase kinase kinase 1; HPK1; Hematopoietic progenitor kinase | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [12] | |||
2 | Protein-peptide | [13] | |||
3 | Reconstituted Complex | [14] | |||
4 | Yeast two hybrid | [15] | |||
Interacting Target Name | PAK-1 protein kinase (PAK1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Serine/threonine-protein kinase PAK 1; PAK-1; p65-PAK; p21-activated kinase 1; Alpha-PAK | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [16] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Affinity Capture-Western | [7] | |||
4 | Reconstituted Complex | [17] | |||
Interacting Target Name | Tyrosine-protein kinase ABL1 (ABL) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Proto-oncogene tyrosine-protein kinase ABL1; Proto-oncogene c-Abl; p150; JTK7; C-ABL; Abl; Abelson tyrosine-protein kinase 1; Abelson murine leukemia viral oncogene homolog 1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [18] | |||
2 | Reconstituted Complex | [19] | |||
3 | Yeast two hybrid | [19] | |||
Interacting Target Name | Focal adhesion kinase 1 (FAK) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein-tyrosine kinase 2; Protein phosphatase 1 regulatory subunit 71; PPP1R71; pp125FAK; p125FAK; FRNK; Focal adhesion kinase-related nonkinase; FAK1; FADK 1; FADK | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [20] | |||
2 | Reconstituted Complex | [21] | |||
3 | Reconstituted Complex | [20] | |||
Interacting Target Name | Protein kinase N2 (PKN2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Serine/threonine-protein kinase N2; Protein-kinase C-related kinase 2; Protein kinase C-like 2; PRKCL2; PRK2; PKN gamma | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [7] | |||
2 | Reconstituted Complex | [22] | |||
Other proteins | [+] 7 Other proteins | + | |||
Interacting Protein Name | Son of sevenless homolog 1 (SOS1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | GF1; GGF1; GINGF; HGF; NS4 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [23] | |||
2 | Affinity Capture-Western | [7] | |||
3 | Affinity Capture-Western | [24] | |||
4 | Reconstituted Complex | [24] | |||
5 | Reconstituted Complex | [25] | |||
Interacting Target Name | GAP-associated tyrosine phosphoprotein p62 (KHDRBS1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Src-associated in mitosis 68 kDa protein; Srcassociated in mitosis 68 kDa protein; Sam68; p68; p21 Ras GTPase-activating protein-associated p62; p21 Ras GTPaseactivating proteinassociated p62; KH domain-containing, RNA-binding, signal transduction-associated protein 1; KH domaincontaining, RNAbinding, signal transductionassociated protein 1; GAPassociated tyrosine phosphoprotein p62 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [26] | |||
2 | Affinity Capture-Western | [27] | |||
3 | Far Western | [26] | |||
4 | Reconstituted Complex | [10] | |||
Interacting Protein Name | Neural Wiskott-Aldrich syndrome protein (WASL) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | N.WASP; NWASP | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [28] | |||
2 | Reconstituted Complex | [29] | |||
3 | Yeast two hybrid | [30] | |||
Interacting Target Name | Wiskott-Aldrich syndrome protein (WAS) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | WASp; IMD2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [31] | |||
2 | Reconstituted Complex | [32] | |||
Interacting Target Name | Apoptosis antigen ligand (CD178) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumor necrosis factor ligand superfamily member 6; TNFSF6; FasL; Fas ligand; FAS antigen ligand; CD95-L; CD95L; CD95 ligand; CD178 antigen; CD178; APTL; APT1LG1; Apoptosis antigen ligand | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Reconstituted Complex | [33] | |||
2 | Yeast two hybrid | [30] | |||
Interacting Target Name | GTPase activating protein (RASA1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RasGAP; RASA; Ras p21 protein activator; Ras GTPase-activating protein 1; p120GAP; GTPase-activating protein; GAP | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [34] | |||
2 | Far Western | [35] | |||
Interacting Protein Name | Lymphocyte cytosolic protein 2 (LCP2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SLP.76; SLP76 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [36] | |||
2 | Reconstituted Complex | [37] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Regulation of Cbl phosphorylation by the Abl tyrosine kinase and the Nck SH2/SH3 adaptor. Oncogene. 2001 Jul 5;20(30):4058-69. | ||||
REF 2 | Characterization of Cbl-Nck and Nck-Pak1 interactions in myeloid FcgammaRII signaling. Exp Cell Res. 1998 Dec 15;245(2):330-42. | ||||
REF 3 | Proteasomal degradation of Nck1 but not Nck2 regulates RhoA activation and actin dynamics. Nat Commun. 2013;4:2863. | ||||
REF 4 | Abl family kinases and Cbl cooperate with the Nck adaptor to modulate Xenopus development. J Biol Chem. 2000 Nov 17;275(46):36472-8. | ||||
REF 5 | The kinase-deficient Src acts as a suppressor of the Abl kinase for Cbl phosphorylation. Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6439-44. | ||||
REF 6 | The SH2 and SH3 domain-containing Nck protein is oncogenic and a common target for phosphorylation by different surface receptors. Mol Cell Biol. 1992 Dec;12(12):5824-33. | ||||
REF 7 | Identification of Grb4/Nckbeta, a src homology 2 and 3 domain-containing adapter protein having similar binding and biological properties to Nck. J Biol Chem. 1999 Feb 26;274(9):5542-9. | ||||
REF 8 | The mammalian-membrane two-hybrid assay (MaMTH) for probing membrane-protein interactions in human cells. Nat Methods. 2014 May;11(5):585-92. | ||||
REF 9 | A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature. 2006 Jan 12;439(7073):168-74. | ||||
REF 10 | Induced direct binding of the adapter protein Nck to the GTPase-activating protein-associated protein p62 by epidermal growth factor. Oncogene. 1997 Oct 9;15(15):1823-32. | ||||
REF 11 | In silico prediction of physical protein interactions and characterization of interactome orphans. Nat Methods. 2015 Jan;12(1):79-84. | ||||
REF 12 | Involvement of hematopoietic progenitor kinase 1 in T cell receptor signaling. J Biol Chem. 2001 Jun 1;276(22):18908-14. | ||||
REF 13 | SRC Homology 2 Domain Binding Sites in Insulin, IGF-1 and FGF receptor mediated signaling networks reveal an extensive potential interactome. Cell Commun Signal. 2012 Sep 14;10(1):27. | ||||
REF 14 | Interaction of hematopoietic progenitor kinase 1 with adapter proteins Crk and CrkL leads to synergistic activation of c-Jun N-terminal kinase. Mol Cell Biol. 1999 Feb;19(2):1359-68. | ||||
REF 15 | SH2/SH3 adaptor proteins can link tyrosine kinases to a Ste20-related protein kinase, HPK1. J Biol Chem. 1997 Oct 31;272(44):27804-11. | ||||
REF 16 | A PAK1-PIX-PKL complex is activated by the T-cell receptor independent of Nck, Slp-76 and LAT. EMBO J. 2001 Feb 1;20(3):457-65. | ||||
REF 17 | Interaction of the Nck adapter protein with p21-activated kinase (PAK1). J Biol Chem. 1996 Oct 18;271(42):25746-9. | ||||
REF 18 | Requirement of multiple SH3 domains of Nck for ligand binding. Cell Signal. 1999 Apr;11(4):253-62. | ||||
REF 19 | Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites. Genes Dev. 1994 Apr 1;8(7):783-95. | ||||
REF 20 | Nck-2 interacts with focal adhesion kinase and modulates cell motility. Int J Biochem Cell Biol. 2002 Jul;34(7):791-805. | ||||
REF 21 | Structure and function of Cas-L, a 105-kD Crk-associated substrate-related protein that is involved in beta 1 integrin-mediated signaling in lymphocytes. J Exp Med. 1996 Oct 1;184(4):1365-75. | ||||
REF 22 | Isolation of a NCK-associated kinase, PRK2, an SH3-binding protein and potential effector of Rho protein signaling. J Biol Chem. 1996 Nov 15;271(46):28772-6. | ||||
REF 23 | Characterization of interactions of Nck with Sos and dynamin. Cell Signal. 1999 Jan;11(1):25-9. | ||||
REF 24 | Binding of NCK to SOS and activation of ras-dependent gene expression. Mol Cell Biol. 1995 Mar;15(3):1169-74. | ||||
REF 25 | Interactions between Src homology (SH) 2/SH3 adapter proteins and the guanylnucleotide exchange factor SOS are differentially regulated by insulin and epidermal growth factor. J Biol Chem. 1996 Oct 11;271(41):25533-8. | ||||
REF 26 | The Nck SH2/SH3 adaptor protein is present in the nucleus and associates with the nuclear protein SAM68. Oncogene. 1997 Jan 16;14(2):223-31. | ||||
REF 27 | Comprehensive analysis of interactions between the Src-associated protein in mitosis of 68 kDa and the human Src-homology 3 proteome. PLoS One. 2012;7(6):e38540. | ||||
REF 28 | A human interactome in three quantitative dimensions organized by stoichiometries and abundances. Cell. 2015 Oct 22;163(3):712-23. | ||||
REF 29 | Nck and phosphatidylinositol 4,5-bisphosphate synergistically activate actin polymerization through the N-WASP-Arp2/3 pathway. J Biol Chem. 2001 Jul 13;276(28):26448-52. | ||||
REF 30 | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. Cell. 2016 Feb 11;164(4):805-17. | ||||
REF 31 | Fyn-binding protein (Fyb)/SLP-76-associated protein (SLAP), Ena/vasodilator-stimulated phosphoprotein (VASP) proteins and the Arp2/3 complex link T cell receptor (TCR) signaling to the actin cytoskeleton. J Cell Biol. 2000 Apr 3;149(1):181-94. | ||||
REF 32 | Wiskott-Aldrich syndrome protein physically associates with Nck through Src homology 3 domains. Mol Cell Biol. 1995 Oct;15(10):5725-31. | ||||
REF 33 | Multiple interactions of the cytosolic polyproline region of the CD95 ligand: hints for the reverse signal transduction capacity of a death factor. FEBS Lett. 2001 Dec 7;509(2):255-62. | ||||
REF 34 | Juxtamembrane tyrosine residues couple the Eph family receptor EphB2/Nuk to specific SH2 domain proteins in neuronal cells. EMBO J. 1997 Jul 1;16(13):3877-88. | ||||
REF 35 | Adaptor protein Nck1 interacts with p120 Ras GTPase-activating protein and regulates its activity. Cell Signal. 2011 Oct;23(10):1651-8. | ||||
REF 36 | Once phosphorylated, tyrosines in carboxyl terminus of protein-tyrosine kinase Syk interact with signaling proteins, including TULA-2, a negative regulator of mast cell degranulation. J Biol Chem. 2012 Mar 9;287(11):8194-204. | ||||
REF 37 | Association of Nck with tyrosine-phosphorylated SLP-76 in activated T lymphocytes. Eur J Immunol. 1999 Apr;29(4):1068-75. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.